Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;25(10):1856-9.
doi: 10.3109/14767058.2012.678442. Epub 2012 Apr 28.

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience

Tze Kin Lau  1 , Mei Ki Chan, Pui Shan Salome Lo, Hon Yee Connie Chan, Wai Sze Kim Chan, Tik Yee Koo, Hoi Yan Joyce Ng, Ritsuko K Pooh
Affiliations
Free PMC article

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience

Tze Kin Lau et al. J Matern Fetal Neonatal Med. 2012 Oct.
Free PMC article

Abstract

Objective: To report the initial experience of noninvasive prenatal diagnosis of fetal Down syndrome (The NIFTY test) in a clinical setting.

Methods: The NIFTY test was offered as a screening test for fetal Down syndrome to pregnant women with a singleton pregnancy at 12 weeks of gestation or beyond. A satisfaction questionnaire was sent to the first 400 patients.

Results: During a 6-month period, 567 NIFTY tests were performed. Over 90% of those studied were ethnic Chinese, and the mean age of the women studied was 36 years. The test was performed at 12-13 weeks of gestation in 49.21%. The median reporting time was 9 days. The test was positive for trisomy 21 in eight cases, and for trisomy 18 in 1 case; all were confirmed by fetal karyotyping. There was no false-positive result. Of the questionnaires, 182 completed responses were received. Over 95% had complete or almost complete resolution of anxiety. Except for one, all were satisfied with the NIFTY test, and all indicated that they would recommend the test to their friends.

Conclusion: The NIFTY test was a highly specific test. Unnecessary invasive tests and associated fetal losses could be avoided in almost all women who have a normal fetus.

PubMed Disclaimer

References

    1. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31:7–15. - PubMed
    1. Leung TY, Chan LW, Law LW, Sahota DS, Fung TY, Leung TN, Lau TK. First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 cases. J Matern Fetal Neonatal Med. 2009;22:300–304. - PubMed
    1. Susanne GO, Sissel S, Ulla W, Charlotta G, Sonja OL. Pregnant women's responses to information about an increased risk of carrying a baby with Down syndrome. Birth. 2006;33:64–73. - PubMed
    1. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487. - PubMed
    1. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, Lu V, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol. 2011;204:205.e1–205.11. - PubMed

Publication types